Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaShield Partners is a specialized clinical trial execution and healthcare technology firm led by a team of seasoned biopharma veterans from companies such as BioMarin and BridgeBio. The company focuses on enhancing the efficiency and effectiveness of Phase III clinical trials, particularly in oncology, ophthalmology, and rare diseases, through optimized patient recruitment and regulatory compliance strategies. Additionally, the firm has developed 'PharmaShield AI,' an AI-powered guardian system designed to verify medicine authenticity and protect the pharmaceutical supply chain from counterfeit products. By combining deep clinical operations expertise with advanced technology, PharmaShield Partners aims to accelerate drug approval timelines and ensure patient safety globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaShield.